dChan - Q Origins Project Archive

Not sure if this been dug yet, but the makers of AMBIEN, Sanofi-Aventis has a very interesting history.

>https://infogalactic.com/info/Sanofi#History

Sanofi

Sanofi was founded in 1973[6] as subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total S.A.), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company.

Synthélabo was founded in 1970 through the merger of two French pharmaceutical laboratories, Laboratoires Dausse (founded in 1834) and Laboratoires Robert & Carrière (founded in 1899). In 1973, the French cosmetics group L’Oréal acquired the majority of its share capital.

Sanofi-Synthélabo was formed in 1999 when Sanofi merged with Synthélabo. The merged companies focused on pharmaceuticals, divesting several businesses soon after the merger.

Aventis

Aventis was formed in 1999 when French company Rhône-Poulenc S.A. merged with the German corporation Hoechst Marion Roussel, which itself was formed from the 1995 merger of Hoechst AG with Cassella, Roussel Uclaf and Marion Merrell Dow. The merged company was based in Schiltigheim, near Strasbourg, France.

At the time of the merger, Rhône-Poulenc's business included the pharmaceutical businesses Rorer, Centeon (blood products), and Pasteur Merieux (vaccines)

Merieux has been in the business of selling blood products, and In the 1980s during the AIDS epidemic, Merieux and other companies were involved in scandals related to HIV-contaminated haemophilia blood products that were sold to developing nations.[12]

Merger : Sanofi-Aventis

Merger: Sanofi-Aventis

Sanofi-Aventis was formed in 2004 when Sanofi-Synthélabo acquired Aventis.

he French government played a strong role, desiring what it called a "local solution", by putting heavy pressure on Sanofi-Synthélabo to raise its bid for Aventis and for Aventis to accept the offer.

One of the largest risks in the deal for both sides, was the fate of the patents protecting Clopidogrel (Plavix) which was one of the top-selling drugs in the world at the time and the major source of Aventis' revenue.

In 2006, Iraqis infected with HIV sued Sanofi and Baxter due to HIV-contaminated haemophilia blood products sold by Merieux in the 1980s.

In 2003 Aventis entered into a collaboration with Regeneron, a New York biotechnology company.

In 2007 Sanofi-Aventis expanded on Aventis' prior relationship with Regeneron.

>>1600847

Thanx, was wondering about that.

Dodge & Cox a new name to me.

Might be worth a dig.

>>1600864

see Q-pharma-mind-blown-COC.png

>>1600827

for possible answer?

>>1600874

Quelle surprise :)

Doing a 19th century dig on S-A next.

>>1600888 <- nice full house

Thanks, anon.

Private sounds juicy.

Anonymous ID: 98929a May 31, 2018, 3:58 p.m. No.1601050 🗄️.is 🔗kun >>1146

These companies go way way back…

>https://pharmaphorum.com/articles/a_history_of-_sanofi/

Sanofi is one of the largest pharmaceutical companies in the world, with a rich history of innovation that dates back over 100 years.

In the 18th Century, in the year 1718, Laboratoires Midy was founded by a family of pharmacists.

This company then merged with fellow French company, Clin Byla, which became the Clin Midy group. Then, in 1980, the Clin Midy group was acquired by Sanofi

Meanwhile, in 1834, another French company Laboratoires Dausse was founded with the aim of manufacturing plant extracts for the preparation of medications for pharmacies.

In 1901, this company merged with Robert &amp, Carrière.

By 1970, the company had merged again to become Synthélabo. Three years later, health and beauty brand L’Oreal acquired a majority stake.

While this was happening, back in 1863, a group of chemists, sales people and workers embarked on the manufacture of dyes, calling the company Hoechst, after the town Höchst in Germany where they were situated.

In 1860, the pharmacist Etienne Poulenc created Wittmann et Poulenc Jeune, passing down the company in time to his two sons.

In 1950, the company synthesised the central nervous system treatment, chlorpromazine, which it later sold to GlaxoSmithKline who marketed the drug as Thorazine. In 1990, it merged with another company to form Rhône-Poulenc Rorer.

Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis.